LOMBARDI, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 5.433
NA - Nord America 1.570
AS - Asia 340
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 4
OC - Oceania 1
Totale 7.421
Nazione #
IT - Italia 4.086
US - Stati Uniti d'America 1.563
GB - Regno Unito 570
SE - Svezia 220
CN - Cina 147
DE - Germania 135
FR - Francia 130
IN - India 66
IE - Irlanda 64
VN - Vietnam 61
RU - Federazione Russa 41
CH - Svizzera 24
EE - Estonia 24
PL - Polonia 24
ZA - Sudafrica 24
UA - Ucraina 23
BG - Bulgaria 21
TG - Togo 18
JO - Giordania 15
CI - Costa d'Avorio 13
BE - Belgio 11
AT - Austria 10
GR - Grecia 9
ID - Indonesia 9
CA - Canada 7
HK - Hong Kong 7
RO - Romania 7
SG - Singapore 7
AE - Emirati Arabi Uniti 5
EU - Europa 5
FI - Finlandia 5
TR - Turchia 5
AL - Albania 4
CZ - Repubblica Ceca 4
IR - Iran 4
LU - Lussemburgo 4
NL - Olanda 4
AO - Angola 3
CL - Cile 3
ES - Italia 3
SM - San Marino 3
UG - Uganda 3
BY - Bielorussia 2
EG - Egitto 2
IL - Israele 2
KW - Kuwait 2
MT - Malta 2
PH - Filippine 2
RE - Reunion 2
UZ - Uzbekistan 2
AM - Armenia 1
AU - Australia 1
DK - Danimarca 1
JP - Giappone 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
SN - Senegal 1
TH - Thailandia 1
TZ - Tanzania 1
Totale 7.421
Città #
Southend 521
Rome 295
Milan 228
Ashburn 214
Fairfield 191
Chandler 130
Houston 111
Bologna 94
Woodbridge 87
Wilmington 80
Cambridge 75
Naples 73
Turin 72
Dublin 64
Seattle 63
Princeton 61
Ann Arbor 58
Padova 47
Palermo 45
Dong Ket 44
Catania 39
Napoli 37
Bari 35
Florence 35
Genoa 35
Bremen 32
Cagliari 31
Westminster 28
Torino 26
Verona 26
Redwood City 24
Nanjing 22
Sofia 20
Lomé 18
Redmond 18
Saint Petersburg 17
Pisa 16
Amman 15
Dearborn 15
Shenyang 15
Berlin 14
Bern 14
Changsha 14
Jinan 14
Messina 14
New York 14
Abidjan 13
Brescia 13
Monza 13
Parma 13
Beijing 12
Dallas 12
Salerno 12
Hebei 11
Medford 11
Pescara 11
Trento 11
Brussels 10
Piacenza 10
Reggio Calabria 10
Tianjin 10
Zhengzhou 10
Bolzano 9
San Diego 9
Trieste 9
Aversa 8
Boardman 8
Marigliano 8
Nanchang 8
Paris 8
Reggio Nell'emilia 8
Barletta 7
Ferrara 7
Modena 7
Muggiò 7
Perugia 7
San Mateo 7
Sarno 7
Seregno 7
Toronto 7
Venezia 7
Vienna 7
Andover 6
Desio 6
Genova 6
Lucca 6
Malang 6
Novara 6
Pavia 6
Pune 6
Rubano 6
Sassari 6
Taranto 6
Abano Terme 5
Avellino 5
Buccinasco 5
Cardito 5
Crotone 5
Livorno 5
Mumbai 5
Totale 3.576
Nome #
Performance del test Quantiferon-TB Gold In-Tube nei pazienti con psoriasi e artrite psorisiaca nello screening e nel trattamento con farmaci anti-TNF-alfa 2.008
Effetto dell’età sulla risposta al mitogeno del test Quantiferon-TB Gold In-Tube nei pazienti pediatrici 1.249
Valutazione del sistema Cepheid Gene Xpert MTB/RIF in campioni respiratori e non respiratori per la diagnosi rapida di tubercolosi 439
Il test Quantiferon-TB Gold In-Tube nel bambino di eta’ inferiore a 5 anni: potenziale utilita’ clinica? 398
null 373
Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates 358
Performance del test Quantiferon-TB Gold In-Tube in campioni biologici diversi dal sangue provenienti da diversi distretti corporei 296
Risposta immunitaria verso Mycobacterium avium paratubercolosis (MAP) in pazienti affetti da Morbo di Crohn 231
QuantiFERON-TB Gold Plus with Chemiluminescence Immunoassay: Do We Need a Higher Cutoff? 167
Andamento in base all’età della concordanza tra Quantiferon e test cutaneo alla tubercolina in bambini e adolescenti a contatto con adulti con tubercolosi polmonare 147
Coexpression of UL20p and gK inhibits cell-cell fusion mediated by herpes simplex virus glycoproteins gD, gH-gL, and wild-type gB or an endocytosis-defective gB mutant and downmodulates their cell surface expression. 129
Improvement of Mycobacterium tuberculosis detection by Xpert MTB/RIF Ultra: A head-to-head comparison on Xpert-negative samples 123
Does biological therapy affect interferon-γ release assay response? A long-term follow-up of patients with psoriasis using QuantiFERON-TB 118
Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF 114
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. 103
Use of transrenal DNA for the diagnosis of extrapulmonary tuberculosis in children: a case of tubercular otitis media. 101
Comparison of MycoPrep and the new MYCO-TB kit: rapid and efficient digestion and decontamination of respiratory specimens for the detection of Mycobacteria 99
Performance of interferon-γ Release Assay for the Diagnosis of Active or Latent Tuberculosis in Children in the First 2 Years of Age 93
First independent evaluation of QuantiFERON-TB Plus performance 84
null 82
Simkania negevensis in Crohn’s Disease 77
Indeterminate Quantiferon-TB Gold In-Tube results in children: association with pneumonia? 76
Utilita’ diagnostica del test Quantiferon-TB nei pazienti pediatrici in un’area a bassa incidenza di tubercolosi con alto tasso di immigrazione 76
Tuberculosis in migrants from 106 countries to Italy, 2008-2014 66
Simultaneous detection of Mycobacterium tuberculosis complex and resistance to Rifampicin and Isoniazid by MDR/MTB ELITe MGB® Kit for the diagnosis of tuberculosis 62
Tuberculosis infection in young children: a screening based on skin and blood testing 60
Predictors of time to sputum smear conversion in patients with pulmonary tuberculosis under treatment 58
Quantiferon-TB performs better in children, including infants, than in adults with active tuberculosis: a multicentre study 57
null 49
Evaluation of trace calls by Xpert MTB/RIF ultra for clinical management in low TB burden settings 37
Quantiferon-TB Gold In-Tube Improves Tuberculosis Diagnosis in Children 36
Liver transplantation during anti-TB treatment 33
Quantitative analysis of interferon-γ release assay response in children with latent and active tuberculosis 31
null 31
Herpes simplex virus glycoprotein K, but not its syncytial allele, inhibits cell-cell fusion mediated by the four fusogenic glycoproteins, gD, gB, gH, and gL 28
IGRA test for TB in COVID-19: role of corticosteroids 23
TB mortality in low-incidence countries: can we reduce it further? 16
MYCO-TB: the first IVD kit suitable for the digestion and decontamination of extra-pulmonary specimens to detect Mycobacteria 1
Totale 7.529
Categoria #
all - tutte 12.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.254


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201990 0 0 0 0 0 0 0 0 0 0 44 46
2019/20201.509 165 68 63 97 109 89 106 148 153 64 194 253
2020/20211.256 159 67 98 93 107 72 74 78 139 102 98 169
2021/20221.074 77 56 62 107 114 79 50 90 78 59 168 134
2022/20231.640 92 104 83 162 112 150 115 147 247 119 168 141
2023/20241.551 116 119 147 152 192 129 179 136 160 175 46 0
Totale 7.529